Gastric juice: a barrier against infectious diseases.

All vertebrates produce gastric acid. Its main function is inactivation of ingested microorganisms. The majority of microbiological pathogens ingested never reaches the intestine because of the gastric barrier. Although gastric hypochlorhydria is fairly common due to atrophic gastritis, gastric surgery or use of inhibitors of gastric acid secretion, the resulting susceptibility to infection has not been studied extensively. Drug-induced blockade of acid secretion leads to gastrointestinal bacterial overgrowth; the clinical significance of this is still controversial. Gastric acidity is known to protect against non-typhoid salmonellosis and cholera and it is suspected that it protects against several parasitic diseases as giardiasis and strongyloides. There is a lack of studies focusing on the impact of the gastric acidic barrier on viral infections. Concerning prion infections only a single study has been performed, demonstrating a possible role of gastric acidity in the protection against foodborne prion disease in mice. The combination of malnutrition and hypochlorhydria may contribute to the high prevalence of gastrointestinal infections in developing countries. Further studies are needed to evaluate the clinical consequences of impaired gastric acidity with respect to susceptibility to infections.

[1]  A. Blum,et al.  Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. , 1994, Gut.

[2]  J. Beynon,et al.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity , 1999, Gut.

[3]  D. Bogchelman,et al.  TRIPLET PREGNANCY AFTER PULSATILE ADMINISTRATION OF GONADOTROPIN RELEASING HORMONE , 1982, The Lancet.

[4]  P. Mackowiak,et al.  The human gastric bactericidal barrier: mechanisms of action, relative antibacterial activity, and dietary influences. , 1989, The Journal of infectious diseases.

[5]  A. Webster,et al.  Microbial and metabolic profile of achlorhydric stomach: comparison of pernicious anaemia and hypogammaglobulinaemia. , 1985, Journal of clinical pathology.

[6]  N. Zamcheck,et al.  Salmonella enteritis , 1971, The American Journal of Digestive Diseases.

[7]  R. Holder,et al.  Increased incidence of bacterial diarrhoea in patients taking gastric acid antisecretory drugs , 1994 .

[8]  G. Guyatt,et al.  A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. , 1998, The New England journal of medicine.

[9]  G. Friedland,et al.  An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals. , 1986, Archives of internal medicine.

[10]  D. Cook,et al.  Gastric alkalinization, pneumonia, and systemic infections: the controversy. , 1995, Scandinavian journal of gastroenterology. Supplement.

[11]  S. Winawer,et al.  Clinical Giardiasis and Intestinal Malabsorption , 1967 .

[12]  P. Arnow,et al.  Brucellosis in a group of travelers to Spain. , 1984, JAMA.

[13]  J. Aponte,et al.  Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia , 2002, American Journal of Gastroenterology.

[14]  Walsh,et al.  Review article: potential gastrointestinal effects of long‐term acid suppression with proton pump inhibitors , 2000, Alimentary pharmacology & therapeutics.

[15]  J. Peters,et al.  Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids , 2007, Journal of Gastrointestinal Surgery.

[16]  R. Slack,et al.  Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study , 1996, BMJ.

[17]  D. Nalin,et al.  CHOLERA, NON-VIBRIO CHOLERA, AND STOMACH ACID , 1978, The Lancet.

[18]  F. Cipollini,et al.  Candidiasis of the small intestine. , 1981, Gastroenterology.

[19]  A. Larner,et al.  Oesophageal candidiasis after omeprazole therapy. , 1992, Gut.

[20]  C. Mowat,et al.  Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. , 1999, Gastroenterology.

[21]  A. Johnsen Phylogeny of the Cholecystokinin/Gastrin Family , 1998, Frontiers in Neuroendocrinology.

[22]  B. Celli,et al.  Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. , 1987, The New England journal of medicine.

[23]  G. Young,et al.  A bifunctional urease enhances survival of pathogenic Yersinia enterocolitica and Morganella morganii at low pH , 1996, Journal of bacteriology.

[24]  A. Boussuges,et al.  Evaluation of left ventricular filling pressure by transthoracic Doppler echocardiography in the intensive care unit , 2002, Critical care medicine.

[25]  J. Hawkey,et al.  Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for salmonella infection , 1994, BMJ.

[26]  I. Barker,et al.  Gastric dysfunction in sheep infected with Trichostrongylus colubriformis, a nematode inhabiting the small intestine. , 1982, International journal for parasitology.

[27]  Henry J. Bartle,et al.  THE GASTRIC SECRETION: ITS BACTERICIDAL VALUE TO MAN , 1925 .

[28]  R. P. Thompson,et al.  Strongyloides stercoralis hyperinfection associated with cimetidine in an immunosuppressed patient: diagnosis by endoscopic biopsy. , 1986, Gut.

[29]  R. Wenzel,et al.  Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. , 1974, The Journal of infectious diseases.

[30]  S. Bhatia,et al.  Gastric bacterial overgrowth accompanies profound acid suppression. , 1995, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[31]  A. Stenderup,et al.  Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole. , 1988, Scandinavian journal of gastroenterology.

[32]  T. Inglis,et al.  Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung , 1993, The Lancet.

[33]  R. Stockbruegger Bacterial overgrowth as a consequence of reduced gastric acidity. , 1985, Scandinavian journal of gastroenterology. Supplement.

[34]  E. C. Wood,et al.  Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. , 1984, British medical journal.

[35]  D. Youngs,et al.  Cimetidine and the potential risk of postoperative sepsis , 1981, The British journal of surgery.

[36]  A. Ruigómez,et al.  Gastric Acid, Acid‐Suppressing Drugs, and Bacterial Gastroenteritis: How Much of a Risk? , 1997, Epidemiology.

[37]  R. Russell,et al.  Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. , 1994, Gastroenterology.

[38]  J. Gray,et al.  Severe Salmonella Gastroenteritis Associated with Hypochlorhydria , 1971, Scottish medical journal.

[39]  N. Blacklow,et al.  Abnormal gastric motor function in viral gastroenteritis. , 1980, Annals of internal medicine.

[40]  F. Cobelens,et al.  Incidence and risk factors of diarrhoea in Dutch travellers: consequences for priorities in pre-travel health advice. , 1998, Tropical medicine & international health : TM & IH.

[41]  C. Mowat,et al.  Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. , 2000, Gastroenterology.

[42]  B. Drasar,et al.  Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. , 1969, Gastroenterology.

[43]  B. Marshall,et al.  Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. , 1990, Gastroenterology.

[44]  J. Hendel,et al.  Omeprazole in the long‐term treatment of severe gastro‐oesophageal reflux disease in patients with systemic sclerosis , 1992, Alimentary pharmacology & therapeutics.

[45]  M. Blaser,et al.  Experimental Campylobacter jejuni infection in humans. , 1988, The Journal of infectious diseases.

[46]  G. Cook Hypochlorhydria and vulnerability to intestinal infection , 1994 .

[47]  Katz,et al.  Gastro‐oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors , 1998, Alimentary pharmacology & therapeutics.

[48]  C. Evans,et al.  Gastric acid secretion and enteric infection in Bangladesh. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[49]  S. Lichtman,et al.  Small bowel bacterial overgrowth syndrome. , 1987, Digestive diseases.

[50]  K. Tobita,et al.  Detection of type B influenza virus genes from biopsied gastric mucosa , 2002, Journal of Gastroenterology.

[51]  J. Aponte,et al.  Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis , 2001, American Journal of Gastroenterology.

[52]  Craig Williams,et al.  Occurrence and significance of gastric colonization during acid-inhibitory therapy. , 2001, Best practice & research. Clinical gastroenterology.

[53]  G. Guyatt,et al.  A Comparison of Sucralfate and Ranitidine for the Prevention of Upper Gastrointestinal Bleeding in Patients Requiring Mechanical Ventilation , 1999 .

[54]  A. Sandvik,et al.  Histamine and the stomach. , 1989, Scandinavian journal of gastroenterology.

[55]  J. Haas,et al.  Zum Krankheitswert der Lamblien-Infektion* , 1967 .

[56]  F. Paradisi,et al.  CAN CIMETIDINE FACILITATE INFECTIONS BY ORAL ROUTE? , 1982, The Lancet.

[57]  G. Simon,et al.  Intestinal flora in health and disease. , 1984, Gastroenterology.

[58]  R. Steffen Antacids--a risk factor in travellers brucellosis? , 1977, Scandinavian journal of infectious diseases.

[59]  A. Sandvik,et al.  Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections , 2002, Expert opinion on drug safety.

[60]  Xiang Xu,et al.  Peripheral regulation of gastric acid secretion , 2000 .

[61]  R. D. De Lisle,et al.  Decreased Gastric Bacterial Killing and Up-Regulation of Protective Genes in Small Intestine in Gastrin-Deficient Mouse , 2003, Digestive Diseases and Sciences.

[62]  E. H. Ellison,et al.  An analysis of ten cases of Salmonella infection on a general surgical service. , 1960, Archives of surgery.

[63]  B. D. Pimparkar,et al.  Anaemia and gastro-intestinal function in ancylostomiasis. , 1982, Journal of Postgraduate Medicine.

[64]  J. Goepel,et al.  SYSTEMIC CANDIDIASIS COMPLICATING ACUTE HEPATIC FAILURE IN PATIENTS TREATED WITH CIMETIDINE , 1981, The Lancet.

[65]  R. Logan,et al.  Potential gastrointestinal effects of long‐term acid suppression with proton pump inhibitors , 2001, Alimentary pharmacology & therapeutics.

[66]  M. Hill,et al.  EFFECT OF CIMETIDINE ON THE GASTRIC BACTERIAL FLORA , 1980, The Lancet.

[67]  E. DeMaria,et al.  Role of gastric colonization in the development of pneumonia in critically ill trauma patients: results of a prospective randomized trial. , 1990, The Journal of trauma.

[68]  S. O'keefe,et al.  Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole , 1996, Alimentary pharmacology & therapeutics.

[69]  Girdwood Rh,et al.  BACTERIAL CHANGES IN THE SMALL INTESTINE IN MALABSORPTIVE STATES AND IN PERNICIOUS ANAEMIA. , 1964 .

[70]  A. Andriulli,et al.  Candida overgrowth in gastric juice of peptic ulcer subjects on short- and long-term treatment with H2-receptor antagonists. , 1983, Digestion.

[71]  H. F. Smith,et al.  Bacteriology of the Stomach Immediately Following Vagotomy: The Growth of Candida Albicans , 1974, Annals of surgery.

[72]  G. Cook Infective gastroenteritis and its relationship to reduced gastric acidity. , 1985, Scandinavian journal of gastroenterology. Supplement.

[73]  A. Haddow,et al.  BLOOD-GROUP AND DISEASE. , 1964, Lancet.

[74]  Sokolova Em SALMONELLA DERBY INFECTIONS AFTER GASTROINTESTINAL SURGERY. , 1965 .

[75]  Andrew F. Hill,et al.  The same prion strain causes vCJD and BSE , 1997, Nature.

[76]  A. Hurst THE CLINICAL IMPORTANCE OF ACHLORHYDRIA * , 1934, British medical journal.

[77]  J. Foster,et al.  OmpR Regulates the Stationary-Phase Acid Tolerance Response of Salmonella enterica Serovar Typhimurium , 2000, Journal of bacteriology.

[78]  D. Wingate Acid reduction and recurrent enteritis , 1990, The Lancet.

[79]  D. Taylor,et al.  Gastric Acidity Protects Mice Against Prion Infection? , 2002, Scandinavian journal of gastroenterology.

[80]  H. Berglund,et al.  Transitory Character of the Achlorhydria During Fever Demonstrated by the Histamine Test. , 1929 .

[81]  A. Aguzzi Peripheral prion pursuit. , 2001, The Journal of clinical investigation.

[82]  L. Gottlieb,et al.  Strongyloidiasis at the boston city hospital , 1968, The American Journal of Digestive Diseases.

[83]  R. Laheij,et al.  Gastric acid‐suppressive therapy and community‐acquired respiratory infections , 2003, Alimentary pharmacology & therapeutics.

[84]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[85]  C. Spirig,et al.  Bactericidal factors in gastric juice , 1992 .

[86]  S. Broitman,et al.  Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro , 1972, Gut.

[87]  S. Sarker,et al.  Non-immunological defence mechanisms of the gut. , 1992, Gut.

[88]  A. L. Kruger Gastric acidity in pulmonary tuberculosis , 1943 .

[89]  S. Ghosh,et al.  Prion proteins and the gut: une liaison dangereuse? , 2001, Gut.

[90]  C. Carpenter,et al.  Experimental canine cholera. I. Development of the model. , 1969, The Journal of infectious diseases.

[91]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[92]  L. Nyhus,et al.  Inhibition of Gastric Acid Secretion by Bacterial Lipopolysaccharide , 1967, Nature.

[93]  Michael A. Rodriguez,et al.  Helicobacter pylori and epidemic Vibrio cholerae 01 infection in Peru , 2000, The Lancet.

[94]  A. Blum,et al.  Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. , 1994, Gut.

[95]  A. Sabin Pathogenesis of poliomyelitis; reappraisal in the light of new data. , 1956, Science.

[96]  Nelis,et al.  Atrophic gastritis during long‐term omeprazole therapy affects serum vitamin B12 levels , 1999, Alimentary pharmacology & therapeutics.

[97]  B. Dale,et al.  Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. , 2003, The Journal of hospital infection.

[98]  F. Collins Salmonellosis in Orally Infected Specific Pathogen-Free C57B1 Mice , 1972, Infection and immunity.

[99]  O. Berger Ueber die ätiologischen Beziehungen zwischen Syphilis und Tabes , 1885 .

[100]  A. Berstad,et al.  Heartburn treatment in primary care: randomised, double blind study for 8 weeks , 1999, BMJ.

[101]  M. Shiner,et al.  Influence of gastric pH on gastric and jejunal flora. , 1967, Gut.

[102]  L. Laine Reply–potential gastrointestinal effects of longterm acid suppression with proton pump inhibitors , 2001 .

[103]  J. Cadranel,et al.  Another example of Strongyloides stercoralis infection associated with cimetidine in an immunosuppressed patient. , 1986, Gut.

[104]  S. Cousens,et al.  Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.

[105]  W. Waddell,et al.  Association of Salmonella enteritis with operations on the stomach. , 1956, The New England journal of medicine.

[106]  Stolte,et al.  Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection , 1999, Alimentary pharmacology & therapeutics.

[107]  A. Blum,et al.  Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. , 1996, Gastroenterology.

[108]  G. Ruiz-Irastorza,et al.  Risk Factors for Esophageal Candidiasis , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[109]  H. Clark,et al.  Rapid inactivation of rotaviruses by exposure to acid buffer or acidic gastric juice. , 1985, The Journal of general virology.

[110]  M. Rousseau,et al.  Association between pulmonary and digestive infections in patients receiving gastric acid-lowering medications for a long duration , 2003, Brain injury.

[111]  Sunoto,et al.  The stomach in malnutrition. , 1977, Archives of disease in childhood.

[112]  T E Woodward,et al.  The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. , 1971, Bulletin of the New York Academy of Medicine.

[113]  A. Blum,et al.  Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. , 1996, Gut.

[114]  H. Dupont,et al.  Immunity in shigellosis. I. Response of man to attenuated strains of Shigella. , 1972, The Journal of infectious diseases.

[115]  O. James,et al.  Bacterial contamination of the small intestine is an important cause of occult malabsorption in the elderly. , 1983, British medical journal.

[116]  A. Sandvik,et al.  CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion. , 1991, The American journal of physiology.

[117]  J. Larner,et al.  Review article: infective complications of therapeutic gastric acid inhibition , 1994, Alimentary pharmacology & therapeutics.

[118]  M. Dilworth,et al.  Problems of adverse pH and bacterial strategies to combat it. , 1999, Novartis Foundation symposium.

[119]  P. Lundborg,et al.  Effect of once daily intravenous and oral omeprazole on 24-hour intragastric acidity in healthy subjects. , 1993, Scandinavian journal of gastroenterology.

[120]  Lamers,et al.  Interdigestive antroduodenal motility and gastric acid secretion , 1998, Alimentary pharmacology & therapeutics.

[121]  D. Owen Attempts at oral infection of rats and mice with trophozoites of Entamoeba histolytica. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[122]  R. Dowling,et al.  Drug‐induced hypochlorhydria causes high duodenal bacterial counts in the elderly , 1998, Alimentary pharmacology & therapeutics.

[123]  S. Gitelson Gastrectomy, achlorhydria and cholera. , 1971, Israel journal of medical sciences.

[124]  S. Khosla,et al.  Gastric acid secretion in typhoid fever. , 1993, Postgraduate medical journal.

[125]  JAMES L. Smith,et al.  The role of gastric acid in preventing foodborne disease and how bacteria overcome acid conditions. , 2003, Journal of food protection.

[126]  P. Cotton,et al.  Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. , 1982, Gut.

[127]  C. Gahan,et al.  The relationship between acid stress responses and virulence in Salmonella typhimurium and Listeria monocytogenes. , 1999, International journal of food microbiology.

[128]  S. Broitman,et al.  Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective. , 1973, Annals of internal medicine.

[129]  J. Walsh,et al.  pH dependence of acid secretion and gastrin release in normal and ulcer subjects. , 1975, The Journal of clinical investigation.

[130]  R. Wood,et al.  Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. , 1995, Journal of the American College of Nutrition.

[131]  A. Aguzzi Neuro-immune connection in spread of prions in the body? , 1997, The Lancet.

[132]  R. Hunt,et al.  Relationship between gastric secretion and infection. , 1987, Gut.

[133]  K. Steinberg Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. , 2002, Critical care medicine.